Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives Consensus Rating of “Buy” from Analysts

Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLY) have received an average recommendation of “Buy” from the eight brokerages that are currently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and three have issued a strong buy rating on the company.

A number of equities analysts have weighed in on RBGLY shares. Royal Bank of Canada reiterated an “outperform” rating on shares of Reckitt Benckiser Group in a research note on Friday, March 7th. Barclays cut Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, February 4th.

Reckitt Benckiser Group Stock Performance

OTCMKTS RBGLY opened at $12.95 on Friday. Reckitt Benckiser Group has a 52 week low of $10.24 and a 52 week high of $14.10. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97. The company has a 50 day moving average price of $13.27 and a 200 day moving average price of $12.66.

Reckitt Benckiser Group Increases Dividend

The business also recently declared a dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 11th will be issued a dividend of $0.2909 per share. The ex-dividend date of this dividend is Friday, April 11th. This is an increase from Reckitt Benckiser Group’s previous dividend of $0.19.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.